Medsol India Overseas Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 22-06-2024
- Paid Up Capital ₹ 1.00 M
as on 22-06-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.63 M
as on 22-06-2024
- Revenue 8.63%
(FY 2022)
- Profit 2.23%
(FY 2022)
- Ebitda -18.31%
(FY 2022)
- Net Worth 15.60%
(FY 2022)
- Total Assets 10.30%
(FY 2022)
About Medsol India Overseas
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.63 M.
Vivek Upreti, Puneet Sharma, and Kaushal Sahani serve as directors at the Company.
- CIN/LLPIN
U51101UP2010PTC039440
- Company No.
039440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2010
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medsol India Overseas Private Limited offer?
Medsol India Overseas Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Calcium Tablet, Calcium Carbonate Tablet.
Who are the key members and board of directors at Medsol India Overseas?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Upreti  | Director | 24-Apr-2015 | Current |
| Puneet Sharma | Director | 08-Oct-2014 | Current |
| Kaushal Sahani | Director | 01-Jun-2013 | Current |
Financial Performance and Corporate Structure Insights of Medsol India Overseas.
Medsol India Overseas Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.63% increase. The company also saw a slight improvement in profitability, with a 2.23% increase in profit. The company's net worth Soared by an impressive increase of 15.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medsol India Overseas?
In 2022, Medsol India Overseas had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Oct 2023 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 30 Oct 2022 | ₹6.40 M | Open |
Hdfc Bank Limited Creation Date: 18 Apr 2022 | ₹1.24 M | Open |
How Many Employees Work at Medsol India Overseas?
Medsol India Overseas has a workforce of 158 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medsol India Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medsol India Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
